Browsing: started

[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha

[ad_1] Amicus started at buy by Jefferies, viewed as “development at reasonable value” [ad_2] Source: Seekingalpha

[ad_1] Allurion started at buy by Roth MKM over weight-loss device potential [ad_2] Source: Seekingalpha

[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha

[ad_1] Amicus started at buy by Jefferies, viewed as “development at reasonable value” [ad_2] Source: Seekingalpha

[ad_1] Allurion started at buy by Roth MKM over weight-loss device potential [ad_2] Source: Seekingalpha

[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha

[ad_1] Amicus started at buy by Jefferies, viewed as “development at reasonable value” [ad_2] Source: Seekingalpha

[ad_1] Allurion started at buy by Roth MKM over weight-loss device potential [ad_2] Source: Seekingalpha

[ad_1] aTyr started at buy by Jefferies, citing efzofitimod potential [ad_2] Source: Seekingalpha